INZY - Inozyme Pharma  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Inozyme Pharma 's activity chart (see below) currently has 37 price targets and 50 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.18% with an average time for these price targets to be met of 9.36 days.

Most recent stock forecast was given by from WELLS FARGO on 19-May-2025. First documented stock forecast 18-Aug-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 19-May-2025

$4

1 years 3 months 28 days ago
(19-May-2025)

1/2 (50%)

$0.01 (0.25%)

38

Buy Since 29-Nov-2021

$12

$8 (200.00%)

1 years 4 months ago
(16-May-2025)

0/11 (0%)

$8.05 (203.80%)

Buy Since 07-Feb-2022

$16

$12 (300.00%)

1 years 5 months 5 days ago
(11-Apr-2025)

0/10 (0%)

$15.11 (1697.75%)

Buy Since 18-Aug-2020

$7

$3 (75.00%)

$15

1 years 6 months 6 days ago
(10-Mar-2025)

0/6 (0%)

$5.94 (560.38%)

Buy Since 04-May-2021

$40

1 years 8 months 3 days ago
(13-Jan-2025)

0/1 (0%)

$22.69 (131.08%)

Show more analysts

Please expand the browser size to see the chart

What is INZY (Inozyme Pharma ) average time for price targets to be met?

On average it took 9 days for the stock forecasts to be reached, with an average price target met ratio of 18.18%.

Which analyst most recently updated their price target on INZY (Inozyme Pharma )?

Which analyst has the most public recommendations on INZY (Inozyme Pharma )?

has 0 price targets and 0 ratings on INZY

Which analyst is the currently most bullish on INZY (Inozyme Pharma )?

Edward White with the highest potential upside of $12

Which analyst is the currently most reserved on INZY (Inozyme Pharma )?

Christopher Raymond with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?